Received Jul 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | 2 | 343DD | IM / LA |
A vaccine intended for the patient?s sibling was mistakenly administered to the patient. The patient stood up to receive the vaccine, and the nurse administered it without confirming the correct recipient. The patient?s vaccination history shows the last Menveo dose was given on 9/16/2022 at 12 years of age. According to the vaccine?s package insert, the patient was not yet due for another dose. Indication per package insert: Booster Vaccination: A single booster dose of MENVEO may be administered to individuals aged 15 through 55 years who are at continued risk for meningococcal disease if at least 4 years have elapsed since a prior dose of a meningococcal . Note: The patient did not have any specific adverse events, treatment, and/or outcomes due to this.
N/A
ADHD
Adderall XR 15 MG Capsule Extended Release 24 Hour 1 capsule in the morning Orally twice a day.
N.K.D.A.
NONE